In the METABRIC-TCGA data sets, PTEN is inactivated in 8% of breast cancers, and activating mutations in PIK3CA, the gene for the p110a catalytic subunit of PI3K, and AKT1 are detected in 40% and 5% of breast cancers, respectively 22, 23. Here, PIK3CA is linked to breast cancer.